Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
21.03
-0.01 (-0.05%)
Jun 2, 2026, 10:16 AM EDT - Market open
Fresenius Medical Care AG Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Fresenius Medical Care AG stock has a consensus rating of "Hold" and an average price target of $26.75. The average 1-year stock price forecast is 27.20% higher than the current stock price, while the lowest is $18.02 (-14.31%) and the highest is $38.1 (+81.17%).
Price Target: $26.75 (+27.20%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Fresenius Medical Care AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 1 | 2 | 2 | 2 |
| Buy | 1 | 0 | 1 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Maintains $26 | Hold | Maintains | $26 | +23.63% | May 21, 2026 |
Financial Forecast
Revenue This Year
19.46B
from 19.63B
Decreased by -0.87%
Revenue Next Year
20.16B
from 19.46B
Increased by 3.64%
EPS This Year
3.05
from 3.36
Decreased by -9.29%
EPS Next Year
4.01
from 3.05
Increased by 31.69%
Financial currency is EUR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.8B | ||
| Avg | 19.5B | ||
| Low | 19.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.9% | ||
| Avg | -0.9% | ||
| Low | -3.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.53 | ||
| Avg | 3.05 | ||
| Low | 2.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.1% | ||
| Avg | -9.3% | ||
| Low | -19.3% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.